Improvement of gene transduction efficiency in T lymphocytes using retroviral vectors

Human Gene Therapy

Volumn 10, Issue 6, 1999, Pages 977-982

  Wu, Ai Guo ^a,b   Liu, Xia ^a   Mazumder, Amitabha ^a   Bellanti, Joseph Alfonso ^b   Meehan, Kenneth Robert ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; LIPOFECTAMINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; NONHUMAN; NORMAL HUMAN; RETROVIRUS; T LYMPHOCYTE;

EID: 0033541588     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018373     Document Type: Article

References (28)

1. BAKER, R.S., and SIMONS, P.J. (1971). Alterations in the susceptibility of cultured mouse cells to transformation by marine sarcoma virus. J. Gen. Virol. 12, 95-104.
2. BLAESE, R.M., BLANKENSTEIN, T., BRENNER, M., COHENHAGUENAUER, O., GANSBACHER, B., RUSSELLS, S., SORRENTINO, B., and VELU, T. (1995a). Vector in cancer therapy: How will they deliver? Cancer Gene Ther. 2, 291-297.
3. - SCID: Initial trial results after 4 years. Science 270, 475-479.
4. - immunodeficient patients. Science 270, 470-474.
5. BORIS-LAWRIE, K., and TEMIN, H.M. (1994). The retroviral vector: Replication cycle and safety considerations for retrovirus-mediated gene therapy. Ann. N.Y. Acad. Sci. 716, 59-71.
6. BUSCHLE, M., COTTEN, M., KIRLAPPOS, H., MECHTLER, K., SCHAFFNER, G., ZAUNER, W., BIRNSTIEL, M.L., and WAGNER, E. (1995). Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex. Hum. Gene Ther. 6, 753-761.
7. CAI, Q., RUBIN, J.T., and LOTZE, M.T. (1995). Genetically marking human cells - results of the first clinical gene transfer studies. Cancer Gene Ther. 2, 125-136.
8. CHUCK, A.S., and PALSSON, B.O. (1996). Consistent and high rates of gene transfer can be obtained using flow-through transduction over wide range of retroviral titer. Hum. Gene Ther. 7, 743-750.
9. COOPER, H.L. (1973). In Drugs and the Cell Cycle. (Academic Press, New York) pp. 137-194.
10. CRYSTAL, R.G. (1995). Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404-410.
11. FALLER, D.V., and BALTIMORE, D. (1984). Liposome encapsulation of retrovirus allows efficient superinfection of resistant cell lines. J. Virol. 49, 269-272.
12. FRITSCH, E.F., and TEMIN, H.M. (1977). Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses. J. Virol. 24, 461-469.
13. HESLOP, H.E., NG, C.Y., LI, C., SMITH, C.A., LOFTIN, S.K., KRANCE, R.A., BRENNER, M.K., and ROOLEY, C.M. (1996). Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Med. 2, 551-555.
14. HODGSON, C., and SOLAIMAN, F. (1996). Virosomes: Cationic liposomes enhance retroviral transduction. Nature Biotechnol. 14, 339-342.
15. HWU, P., YANNELLI, J., KRIELGER, M., ANDERSON, W.F., PEREZ, C., CHIANG, Y., SCHWARZ, S., COWHERD, R., DELGADO, C., MULE, J., and RESENBERG, S.A. (1993). Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-α cDNA for the gene therapy of cancer in humans. J. Immunol. 150, 4104-4115.
16. LUCAS, Z.J. (1977). Regulatory control of nucleic acid synthesis during blastogenesis of lymphocytes in culture. In Drugs and Cell Regulation. E. Mihich, ed. (Academic Press, London) pp. 159-180.
17. MUENCHAU, D.D., FREEMAN, S.M., CORNETTA, K., ZWIEBEL, J.A., and ANDERSON, W.F. (1990). Analysis of retroviral packaging lines for generation of replication-competent virus. Virology 176, 262-265.
18. MULLEN, C.A., SNITZER, K., CULVER, K.W., MORGAN, R.A., ANDERSON, W.F., and BLAESE, R.M. (1996). Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: Long-term expression in vivo of genes introduced with a retroviral vector. Hum. Gene Ther. 7, 1123-1129.
19. MULLIGAN, R.C. (1993). The basic science of gene therapy. Science 260, 926-932.
20. OLSEN, J.C., and SECHELSKI, J. (1995). Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA. Hum. Gene Ther. 6, 1195-1202.
21. ONODERA, M., ARIGA, T., KAWAMURA, N., KOBAYASHI, I., OHTSU, M., YAMADA, M., AME, A., FURUTA, H., OKANO, M., MATSUMOTO, S., KOTANI, H., MCGARRITY, G.J., BLAESE, R.M., and SAKIYAMA, Y. (1998). Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency. Blood 91, 30-36.
22. SANES, J.R., RUBENSTEIN, J.L., and NICOLAS, J.F. (1986). Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryo. EMBO J. 5, 3133-3142.
23. SCHWARTZ, B., BENOIST, C., ABDALLAH, B., SCHERMAN, D., BEHR, J.P., and DEMENEIX, B.A. (1995). Lipospermine-based gene transfer into the newborn mouse brain is optimized by a low lipospermine/DNA charge ratio. Hum. Gene Ther. 6, 1515-1524.
24. SMITH, K.A. (1988). Interleukin-2: Inception, impact, and implications. Science 240, 1169-1176.
25. SMYTHE, J.A., SUN, D., THOMSON, M., MARKHAM, P.D., REITZ, M.S., JR., GALLO, R.C., and LISZIEWICZ, J. (1994). A Rev-inducible mutant gag gene stably transferred into T lymphocytes: An approach to gene therapy against human immunodeficiency virus type 1 infection. Proc. Natl. Acad. Sci. U.S.A. 91, 3657-3661.
26. SPRINGETT, G.M., MOEN, R.C., ANDERSON, S., BLEASE, R.M., and ANDERSON, W.F. (1989). Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J. Virol. 63, 3865-3869.
27. TIBERGHIEN, P., REYNOLDS, C.W., KELLER, J., SPENCE, S., DESCHASEAUX, M., CERTOUX, J.M., CONTASSOT, E., MURPHY, W.J., LYONS, R., CHIANG, Y., HERVE, P., LONGO, D.L., and RUSCETTI, F.W. (1994). Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: An approach for specific in vivo donor T cell depletion after bone marrow transplantation? Blood 84, 1333-1341.
28. YANG, Y., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.